Session Information
-
WCLC 2017
18th World Conference on Lung Cancer
Conference Program for the 18th World Conference on Lung Cancer in Yokohama, Japan
Download PDF of the Conference Program: Click Here.
Onsite Conference Program Addendum (17/10/2017): Click Here.
Download PDF of the Abstract Book: Click Here.
Financial Disclosure Summary (PDF): Click Here.Presentation Date(s):- Oct 15 - 18, 2017
- Total Presentations: 2295
October 14 Sat
Oct 14 Sunday
October 15 Sun
Oct 15 Monday
October 16 Mon
Oct 16 Tuesday
October 17 Tue
Oct 17 Wednesday
October 18 Wed
Oct 18
-
+
MS 21 - Being Mortal: Learning from ZEN
- 11:00 - 12:30
- 10/18/2017
- Location: Room 316
- Type: Mini Symposium
- Track: Nursing/Palliative Care/Ethics
- Moderators:M. Cummins, K. Kubota
-
+
MS 21.01 - Spirituality in Asia
11:00 - 11:40 | Presenter: Nanrei Yokota
- Abstract
Loading... -
+
MS 21.02 - Meditation: From the Temples to the Clinic
11:40 - 12:00 | Presenter: Alejandro Chaoul
- Abstract
Loading... -
+
MS 21.03 - Self-Care: "Provider, Heal Thyself"
12:00 - 12:20 | Presenter: Maria Ftanou
- Abstract
Loading... -
+
MS 21.04 - Q&A
12:20 - 12:30
- Abstract
No abstract available for this presentation
-
+
MS 22 - The Cost of Lung Cancer
- 11:00 - 12:30
- 10/18/2017
- Location: Room 502
- Type: Mini Symposium
- Track: Epidemiology/Primary Prevention/Tobacco Control and Cessation
- Moderators:R.J. Kelly, T. Sobue
-
+
MS 22.01 - The Economic Burden of Lung Cancer
11:00 - 11:25 | Presenter: Natasha B Leighl
- Abstract
No abstract available for this presentation
-
+
MS 22.03 - Health Disparities and the Costs of Tobacco Related Diseases
11:25 - 11:50 | Presenter: Peter Boyle
- Abstract
No abstract available for this presentation
-
+
MS 22.04 - The Economic World of Tobacco Free Investments
11:50 - 12:15 | Presenter: Bronwyn King
- Abstract
Loading... -
+
MS 22.05 - Q&A
12:15 - 12:30
- Abstract
No abstract available for this presentation
-
+
OA 10 - Liquid Biopsy for Genomic Alterations
- 11:00 - 12:30
- 10/18/2017
- Location: F201 + F202 (Annex Hall)
- Type: Oral
- Track: Advanced NSCLC
- Moderators:Adrian G. Sacher, Pasi A Jänne
-
+
OA 10.01 - Detection of EGFR mutations from plasma ctDNA in the osimertinib Phase III trial (AURA3): comparison of three plasma assays
11:00 - 11:10 | Presenter: Myung-Ju Ahn | Author(s): Ji-Youn Han, C. Tsai, A. Delmonte, T. Hsia, J. Laskin, S. Kim, Y. He, T. Hida, M. Maemondo, T. Kato, S. Jenkins, A. Markovets, K.S. Thress, T. Mok
- Abstract
Loading... -
+
OA 10.02 - Unique Genetic Profiles from Circulating Cell-Free DNA of Cerebrospinal Fluid in Leptomeningeal Metastases of EGFR Mutant NSCLC
11:10 - 11:20 | Presenter: Benyuan Jiang | Author(s): Y. Li, Jin -Ji Yang, X. Yang, Qing Zhou, W. Zhong, X. Zhang, Yi-Long Wu
- Abstract
Loading... -
+
OA 10.03 - Liquid Biopsy in the Lung Cancer Clinic: A Prospective Study of Plasma DNA next Generation Sequencing to Guide Matched Therapy
11:20 - 11:30 | Presenter: Joshua K Sabari | Author(s): D. Stephens, A. Ni, A. Lee, Nick Pavlakis, S. Clarke, C.I. Diakos, M. Offin, S. Datta, N. Tandon, M. Duboff, J. Simpronio, A. Martinez, J. Isbell, Valerie W Rusch, D. Jones, Andreas Rimner, S. Henderson, C. Raymond, L. Lim, M. Li, Gregory J Riely, Charles M Rudin, Bob T. Li
- Abstract
Loading... -
+
OA 10.04 - Discussant - OA 10.01, OA 10.02, OA 10.03
11:30 - 11:45 | Presenter: R. Hui
- Abstract
No abstract available for this presentation
-
+
OA 10.05 - Non-Invasive Molecular Profiling in NSCLC by Targeted and Whole Exome Analysis of Plasma cfDNA
11:45 - 11:55 | Presenter: Dana W.Y. Tsui | Author(s): M.L. Cheng, J.L. Yang, M. Shady, P. Ulz, E. Heitzer, N.D. Socci, V. Seshan, M. Offin, D. Stephens, A. Makhnin, N. Tandon, S. Datta, D.S. Selcuklu, K. Huberman, K. Vanness, E. Gedvilaite, A. Viale, Maria E Arcila, Marc Ladanyi, J.E. Chaft, Charles M Rudin, M.F. Berger, D.B. Solit, Bob T. Li
- Abstract
Loading... -
+
OA 10.06 - Longitudinal Mutation Monitoring in Plasma by Deep Sequencing as a Potential Predictor of Disease Progression in NSCLC
11:55 - 12:05 | Presenter: John Jiang | Author(s): H. Adams, M. Lange, S. Siemann, M. Feldkamp, S. Schulze, S. Froehler, S. Yaung, L. Yao, A. Balasubramanyam, N. Tikoo, H..J. Achenbach, R. Krügel, J.F. Palma, André Rosenthal
- Abstract
Loading... -
+
- Abstract
Loading... -
+
OA 10.08 - Discussant - OA 10.05, OA 10.06, OA 10.07
12:15 - 12:30 | Presenter: Naoko Aragane
- Abstract
No abstract available for this presentation
-
+
OA 11 - Reducing Burden: Patient-Centered Care
- 11:00 - 12:30
- 10/18/2017
- Location: Room 313 + 314
- Type: Oral
- Track: Nursing/Palliative Care/Ethics
- Moderators:Beth Ivimey, E. Bernicker
-
+
OA 11.01 - Impact of Tobacco Smoking on the Humanistic and Financial Burden of Advanced Non-Small Cell Lung Cancer (A-NSCLC)
11:00 - 11:10 | Presenter: Oana Chirita | Author(s): R. Wood, G. Taylor-Stokes, M. Lees
- Abstract
Loading... -
+
OA 11.02 - Exercise Improves Functional Capacity in Patients with Advance Stage Lung Cancer
11:10 - 11:20 | Presenter: Morten Quist
- Abstract
Loading... -
+
OA 11.03 - Reducing Lung Cancer Mortality in Disparate Populations through Cancer-Community Awareness Access Research and Education (C-CARE)
11:20 - 11:30 | Presenter: Lovoria B Williams | Author(s): T.V. Joshua, S. Looney, A. McCall, M. Tingen
- Abstract
Loading... -
+
OA 11.04 - Effect of Early Palliative Care on Aggressiveness of Cancer Care near End of Life in Lung Cancer Patient
11:30 - 11:40 | Presenter: Wandee Chanprasertpinyo | Author(s): S. Semsarn, V. Tangsujaritvijit, N. Ngamphaiboon, Thanyanan Reungwetwattana, S. Chaiviboontham, J. Konmun, V. Sachdev, P. Chansriwong
- Abstract
Loading... -
+
OA 11.05 - Discussant - OA 11.01, OA 11.02, OA 11.03, OA 11.04
11:40 - 11:55 | Presenter: J.S. Lee
- Abstract
No abstract available for this presentation
-
+
OA 11.06 - Lung Cancer Diagnosis and Assessment as a System Design Problem: Creating an Award Winning Program with Patient Advocates as Co-Designers
11:55 - 12:05 | Presenter: Jason Pantarotto | Author(s): M. Fung-Kee-Fung, D. Maziak, J. Smylie, L. Taylor, T. Timlin, T. Cacciotti, Patrick James Villeneuve, C. Dennie, C. Bornais, J. Aquino, P. Wheatley-Price, R. Ozer, David James Stewart
- Abstract
Loading... -
+
OA 11.07 - Enhancing Lung Cancer (LC) Care in the Community Setting Through a Patient Advocacy 'Centers of Excellence' (COE) Program
12:05 - 12:15 | Presenter: Raymond U. Osarogiagbon | Author(s): Luis E Raez, L. Fine
- Abstract
Loading... -
+
OA 11.08 - Discussant - OA 11.06, OA 11.07
12:15 - 12:30 | Presenter: Kazuo Hasegawa
- Abstract
No abstract available for this presentation
-
+
OA 12 - Emerging Genomic Targets
- 11:00 - 12:30
- 10/18/2017
- Location: F203 + F204 (Annex Hall)
- Type: Oral
- Track: Advanced NSCLC
- Moderators:H. Akita, Maurice Pérol
-
+
OA 12.01 - The Preclinical and Clinical Activity of Poziotinib, a Potent, Selective Inhibitor of EGFR Exon 20 Mutant NSCLC
11:00 - 11:10 | Presenter: Y.Y. Elamin | Author(s): Jacqulyne Ponville Robichaux, Vincent K Lam, Anne Tsao, C. Lu, G. Blumenschein, J. Kurie, Julie R Brahmer, S. Li, T. Chen, A. Estrada-Bernal, A. Truini, M. Nilsson, A.T. Le, Z. Tan, S. Zhang, Robert C. Doebele, K. Politi, Z. Yang, S. Liu, Kwok-Kin Wong, John V Heymach
- Abstract
Loading... -
+
OA 12.02 - Final Results of a Phase 2 Study of the hsp90 Inhibitor Luminespib (AUY922) in NSCLC Patients Harboring EGFR Exon 20 Insertions
11:10 - 11:20 | Presenter: Zofia Piotrowska | Author(s): D.B. Costa, M. Huberman, Geoffrey R. Oxnard, Justin F Gainor, R. Heist, I.T. Lennes, A. Muzikansky, Alice Shaw, C.G. Azzoli, Lecia V Sequist
- Abstract
Loading... -
+
OA 12.03 - Clinical Features of Advanced Lung Cancer Harboring HER2 Aberrations: A Large Prospective Cohort Study (HER2-CS STUDY)
11:20 - 11:30 | Presenter: Shinobu Hosokawa | Author(s): A. Bessho, K. Ninomiya, T. Tanaka, N. Ishikawa, M. Yamasaki, T. Shibayama, K. Aoe, T. Kozuki, N. Fujimoto, K. Gemba, Y. Ueda, M. Inoue, T. Murakami, Shoichi Kuyama, H. Kawai, K. Fujitaka, K. Inoue, M. Takata, H. Yanai, K. Hotta, K. Kiura
- Abstract
Loading... -
+
OA 12.04 - Discussant - OA 12.01, OA 12.02, OA 12.03
11:30 - 11:40 | Presenter: Christina S Baik
- Abstract
No abstract available for this presentation
-
+
OA 12.05 - Spectrum of 1,014 Somatic BRAF Alterations Detected in Cell-Free DNA of Patients with Advanced Non-Small Cell Lung Cancer
11:40 - 11:50 | Presenter: Trever G Bivona | Author(s): V.M. Raymond, R.B. Lanman, R.J. Nagy, K.C. Banks, Y.K. Chae, J.M. Clarke, Jeffrey Crawford, David R. Gandara, John V Heymach
- Abstract
Loading... -
+
OA 12.06 - Plasma Genomic Profiling and Outcomes of Patients with MET Exon 14-Altered NSCLCs Treated with Crizotinib on PROFILE 1001
11:50 - 12:00 | Presenter: Alexander Drilon | Author(s): J.W. Clark, J. Weiss, Sai-Hong Ignatius Ou, D. Ross Camidge, Ben J Solomon, G. Otterson, L.C. Villaruz, Gregory J Riely, R. Heist, G.I. Shapiro, D.A. Murphy, Y. Liu, S.C. Wang, T. Usari, K.D. Wilner, Paul K. Paik
- Abstract
Loading... -
+
OA 12.07 - LOXO-292, a Potent, Highly Selective RET Inhibitor, in MKI-Resistant RET Fusion-Positive Lung Cancer Patients with and without Brain Metastases
12:00 - 12:10 | Presenter: Vamsidhar Velcheti | Author(s): T.M. Bauer, V. Subbiah, M.E. Cabanillas, N. Lakhani, L.J. Wirth, Geoffrey R. Oxnard, M.H. Shah, E.J. Sherman, S. Smith, T. Eary, S. Cruickshank, B.B. Tuch, K. Ebata, M. Nguyen, S. Corsi-Travali, S. Rothenberg, Alexander Drilon
- Abstract
Loading... -
+
OA 12.08 - Genomic Analysis of Non-Small Cell Lung Cancer (NSCLC) Cases with Focal and Non-Focal MET Amplification
12:10 - 12:20 | Presenter: Sai-Hong Ignatius Ou | Author(s): D. Pavlick, P.J. Stephens, Jeffrey S. Ross, V.A. Miller, Siraj M Ali, A.B. Schrock
- Abstract
Loading... -
+
OA 12.09 - Discussant - OA 12.05, OA 12.06, OA 12.07, OA 12.08
12:20 - 12:30 | Presenter: Julien Mazieres
- Abstract
No abstract available for this presentation
-
+
OA 13 - Immuno-Biology
- 11:00 - 12:30
- 10/18/2017
- Location: Room 301 + 302
- Type: Oral
- Track: Immunology and Immunotherapy
- Moderators:Hiroyuki Suzuki, Scott N. Gettinger
-
+
OA 13.01 - CD38-Mediated Immunometabolic Suppression as a Mechanism of Resistance to PD-1/PD-L1 Axis Blockade
11:00 - 11:10 | Presenter: Don Lynn Gibbons | Author(s): L. Chen, L. Diao, Y. Yang, X. Yi, B..L. Rodriguez, Y. Li, J. Rodriguez-Canales, X. Liu, A. Huang, Q. Zhao, D. Peng, J.J. Fradette, P. Tong, C. Ungewiss, Y. Fan, D. Peng, P. Villalobos, E. Dmitrovsky, Vassiliki A Papadimitrakopoulou, J. Wang, L.A. Byers, John V Heymach, S. Ullrich, Ignacio I. Wistuba, X. Qin
- Abstract
Loading... -
+
OA 13.02 - Distribution of PD-L1 Tumor Expression by Assay Type in Patients with Metastatic NSCLC (MNSCLC)
11:10 - 11:20 | Presenter: Vamsidhar Velcheti | Author(s): X. Cao, F.X. Liu, P.D. Patwardhan
- Abstract
Loading... -
+
OA 13.03 - Wide Expression of Alternative Immune Checkpoint Molecules, B7x and HHLA2, in PD-L1 Negative Human Lung Cancers
11:20 - 11:30 | Presenter: Haiying Cheng | Author(s): Alain Borczuk, M. Janakiram, X. Ren, J. Lin, A. Assal, Balazs Halmos, R. Perez-Soler, X. Zang
- Abstract
Loading... -
+
OA 13.04 - Discussant - OA 13.01, OA 13.02, OA 13.03
11:30 - 11:45 | Presenter: Charles Andrew Butts
- Abstract
No abstract available for this presentation
-
+
OA 13.05 - Immune, Molecular and T Cell Repertoire Landscape of 235 Resected Non-Small Cell Lung Cancers and Paired Normal Lung Tissues
11:45 - 11:55 | Presenter: Alexandre Reuben | Author(s): R. Gittelman, J. Zhang, R. Chen, K. Quek, L. Vence, I. Fernandez-Cubelo, C. Behrens, J. Gao, E. Yusko, R. Emerson, S. Benzeno, M. Vignali, C. Tipton, A. Jalali, W. Lee, C. Wu, J. Li, X. Wu, Y. Ye, A. Eterovic, L. Little, C. Gumbs, C. Bernatchez, C.L. Haymaker, M. Forget, L. Federico, T. Cascone, H. Robins, E. Roarty, J. Rodriguez, E. Parra, J. Wargo, J. Allison, P. Sharma, J. Zhang, Jack Lee, B. Sepesi, Stephen Swisher, Don Lynn Gibbons, John V Heymach, A. Futreal, Ignacio I. Wistuba, Jianjun Zhang
- Abstract
Loading... -
+
OA 13.06 - Co-Expression of IDO1 and PD-L1 Indicates More Aggressive Features of Lung Adenocarcinoma
11:55 - 12:05 | Presenter: Yuka Kozuma | Author(s): Kazuki Takada, Gouji Toyokawa, K. Kohashi, M. Shimokawa, F. Kinoshita, T. Matsubara, Naoki Haratake, Shinkichi Takamori, Takaki Akamine, F. Hirai, T. Tagawa, Y. Oda, Y. Maehara
- Abstract
Loading... -
+
OA 13.07 - Contraction of T Cell Clonality in Lung Cancer Metastases
12:05 - 12:15 | Presenter: Aaron S. Mansfield | Author(s): H. Ren, S. Sutor, R. Dronca, S. Park, S.N. Markovic, W. Nevala, J. Jen, M.C. Aubry, H. Dong
- Abstract
Loading... -
+
OA 13.08 - Discussant - OA 13.05, OA 13.06, OA 13.07
12:15 - 12:30 | Presenter: Hiroshi Kagamu
- Abstract
No abstract available for this presentation
-
+
OA 14 - New Paradigms in Clinical Trials
- 11:00 - 12:30
- 10/18/2017
- Location: Room 311 + 312
- Type: Oral
- Track: Clinical Design, Statistics and Clinical Trials
- Moderators:Alex Adjei, Eun Kyung Cho
-
+
OA 14.01 - The Impact of Measurement Variability on Response Categorization in Oncology Trials
11:00 - 11:10 | Presenter: Soon Ho Yoon | Author(s): J. Yoon, S. Hahn, Jin Mo Goo, D. Kim
- Abstract
Loading... -
+
OA 14.02 - Rethinking Progression-Free Survival (PFS) as a Clinical Trials Surrogate for Overall Survival (OS)
11:10 - 11:20 | Presenter: David James Stewart | Author(s): D. Bosse, A. Ocana, Glenwood Goss, D. Jonker
- Abstract
Loading... -
+
OA 14.03 - Ontario's Bundled Payment System for Systemic Therapy Supports Lung Cancer Trials
11:20 - 11:30 | Presenter: William Kenneth Evans | Author(s): T. Kais-Prial, R. Fung, L. Forbes
- Abstract
Loading... -
+
OA 14.04 - Discussant - OA 14.01, OA 14.02, OA 14.03
11:30 - 11:45 | Presenter: George R. Simon
- Abstract
No abstract available for this presentation
-
+
OA 14.05 - Phase 2 Basket Trial of Ado-Trastuzumab Emtansine in Patients with HER2 Mutant or Amplified Lung Cancers
11:45 - 11:55 | Presenter: Bob T. Li | Author(s): R. Shen, D. Buonocore, Z.T. Olah, A. Ni, M.S. Ginsberg, G. Ulaner, W. Weber, Dana W.Y. Tsui, M. Offin, H.H. Won, Marc Ladanyi, Gregory J Riely, D.B. Solit, D.M. Hyman, Charles M Rudin, M.F. Berger, J. Baselga, M. Scaltriti, Maria E Arcila, Mark G Kris
- Abstract
Loading... -
+
OA 14.06 - Entrectinib in Patients with Locally Advanced or Metastatic ROS1 Fusion-Positive Non-Small Cell Lung Cancer (NSCLC)
11:55 - 12:05 | Presenter: Myung-Ju Ahn | Author(s): Byoung Chul Cho, S. Siena, Alexander Drilon, F. De Braud, Matthew G Krebs, T. John, C. Karapetis, A.D. Johnson, E. Chow-Maneval, P.S. Multani, Robert C. Doebele
- Abstract
Loading... -
+
OA 14.07 - Progress in Lung Squamous Cell Carcinoma from the Lung-MAP Master Protocol (S1400) Sub-Studies S1400A, S1400B, S1400C and S1400D
12:05 - 12:15 | Presenter: Roy S. Herbst | Author(s): Mary Redman, David R. Gandara, Fred R. Hirsch, Philip Christopher Mack, Hossein Borghaei, Corey J Langer, J. Wade, J.A. Engelman, Martin Edelman, K. Albain, Primo Lara, C. Aggarwal, M.A. Socinski, Scott N. Gettinger, Lyudmila Bazhenova, S.N. Waqar, Francisco Robert, G.J. Kiefer, Jeffrey Bradley, Jeffrey Crawford, E. McGary, N.M. Rafique, D. Petro, P.C. Hoffman, Y. Zhou, J. Miao, K. Griffin, S. McDonough, C. Miwa, S. Malik, V.A. Miller, E.V. Sigal, S. Adam, C.D. Blanke, Karen Kelly, Vassiliki A Papadimitrakopoulou
- Abstract
Loading... -
+
OA 14.08 - Discussant - OA 14.05, OA 14.06, OA 14.07
12:15 - 12:30 | Presenter: Fiona Blackhall
- Abstract
No abstract available for this presentation
-
+
PC 03 - 3-1 What is the Optimal Sequence of ALK-TKI for ALK-Positive Lung Cancer? (Alectinib First or Crizotinib First)
- 11:00 - 11:40
- 10/18/2017
- Location: Room 303 + 304
- Type: Pros & Cons
- Track: Chemotherapy/Targeted Therapy
- Moderators:Rafal Dziadziuszko, Y.O. Tan
-
+
PC 03.01 - Crizotinib First
11:00 - 11:20 | Presenter: Sai-Hong Ignatius Ou
- Abstract
Loading... -
+
PC 03.02 - Alectinib First
11:20 - 11:40 | Presenter: Kazuhiko Nakagawa
- Abstract
No abstract available for this presentation
-
+
PC 03 - 3-2 Which Do you Prefer: Liquid Biopsy or Tissues Biopsy for Molecular Diagnosis?
- 11:40 - 12:30
- 10/18/2017
- Location: Room 303 + 304
- Type: Pros & Cons
- Track: Chemotherapy/Targeted Therapy
- Moderators:Rafal Dziadziuszko, Y.O. Tan
-
+
PC 03.03 - Liquid Biopsy
11:40 - 12:00 | Presenter: Heather A Wakelee
- Abstract
Loading... -
+
PC 03.04 - Tissues Biopsy
12:00 - 12:20 | Presenter: Keith M Kerr
- Abstract
No abstract available for this presentation
-
+
PC 03.05 - Q&A
12:20 - 12:30
- Abstract
No abstract available for this presentation
-
+
ES 09 - Recent Progress in the Management of Small Cell Lung Cancer
- 14:30 - 16:15
- 10/18/2017
- Location: Room 501
- Type: Educational Session
- Track: SCLC/Neuroendocrine Tumors
- Moderators:David S Ettinger, Kenneth Obyrne
-
+
ES 09.01 - Genomics and Translational Research
14:30 - 14:50 | Presenter: Charles M Rudin
- Abstract
No abstract available for this presentation
-
+
ES 09.02 - Cytotoxic Chemotherapy
14:50 - 15:10 | Presenter: Yoichi Nakanishi
- Abstract
Loading... -
+
ES 09.03 - Immunotherapy
15:10 - 15:30 | Presenter: Caicun Zhou | Author(s): M. Qiao
- Abstract
Loading... -
+
ES 09.05 - Management of Paraneoplastic Syndromes in SCLC
15:30 - 15:50 | Presenter: Lucio Crinò
- Abstract
Loading... -
+
ES 09.06 - NCI’s Small Cell Lung Cancer Consortium: New Answers to Old Questions
15:50 - 16:10 | Presenter: Peter Ujhazy
- Abstract
Loading... -
+
ES 09.07 - Q&A
16:10 - 16:15
- Abstract
No abstract available for this presentation